Journal Article
Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes
April 11, 2025
Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Desi Peneva, MS, Karen Van Nuys, PhD
Research
All Research Featured Research
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
February 18, 2025
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure
October 29, 2024
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Testimony
Testimony on the Role of Pharmacy Benefit Managers
September 11, 2024
Featured Experts: Karen Van Nuys, PhD
News
PBM Market Concentration Varies Among Payer Types
September 10, 2024
Featured Experts: Karen Van Nuys, PhD, Dima M. Qato, PharmD, MPH, PhD
Journal Article
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail Pharmacies
September 10, 2024
Featured Experts: Dima M. Qato, PharmD, MPH, PhD, Karen Van Nuys, PhD
Evidence Base
A Patient-Focused, Evidence-Driven Approach to PBM Reform
July 22, 2024
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD, Stephanie Hedt, MPP, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Neeraj Sood, PhD, Erin Trish, PhD
News
Schaeffer Center Researchers Make an Impact in Washington
April 25, 2024
Featured Experts: Darius Lakdawalla, PhD, Erin Trish, PhD, Karen Van Nuys, PhD, Neeraj Sood, PhD, Alice Chen, PhD
News
Medicare Part D Plans Increased Restrictions on Drug Coverage
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Journal Article
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Comment Letter
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
January 19, 2024
Featured Experts: Darius Lakdawalla, PhD, Joseph Grogan, JD, Stephanie Hedt, MPP, Barry Liden, JD, Erin Trish, PhD, Karen Van Nuys, PhD
Comment Letter
Comments in Response to a CBO Call for New Research on Obesity
November 2, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD, Alison Sexton Ward, PhD, Bryan Tysinger, PhD, Barry Liden, JD
Perspective
How the Secrecy of Middlemen Inflates Drug Prices
October 14, 2023
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Comment Letter
Comments to CMS on Proposed Guidance for Coverage with Evidence Development
August 25, 2023
Featured Experts: Alice Chen, PhD, Joseph Grogan, JD, Mireille Jacobson, PhD, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Eugene Lin, MD, MS, Karen Van Nuys, PhD, William Padula, PhD, Alison Sexton Ward, PhD, Julie Zissimopoulos, PhD
Journal Article
Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share
June 6, 2023
Featured Experts: Alice Chen, PhD, Maria-Alice Manetas, Karen Van Nuys, PhD
Comment Letter
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
April 17, 2023
Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD
Testimony
Testimony on Pharmacy Benefit Managers and the Prescription Drug Supply Chain
March 30, 2023
Featured Experts: Karen Van Nuys, PhD
Perspective
Ending Health Insurance for Generic Drugs Would Save Patients Money
March 28, 2023
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Evidence Base
Eli Lilly Is Cutting Insulin Prices and Capping Copays at $35 – 5 Questions Answered
March 3, 2023
Featured Experts: Dana Goldman, PhD, Karen Van Nuys, PhD